相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ProSTAR: A phase lb/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Mary-Ellen Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Understanding histone H3 lysine 36 methylation and its deregulation in disease
Jie Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3/-CATENIN signal pathway
Xinxin Tian et al.
IUBMB LIFE (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Yan Zhang et al.
NATURE COMMUNICATIONS (2018)
NSD2 is a conserved driver of metastatic prostate cancer progression
Alvaro Aytes et al.
NATURE COMMUNICATIONS (2018)
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes
Shivashankar Damodaran et al.
BMC CANCER (2017)
Identifying Dysregulated Epigenetic Enzyme Activity in Castrate Resistant Prostate Cancer Development
Jin-Hee Lee et al.
ACS CHEMICAL BIOLOGY (2017)
Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy
Patrice Desmeules et al.
DIAGNOSTIC PATHOLOGY (2015)
Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation
Relja Popovic et al.
PLOS GENETICS (2014)
Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
Irfan A. Asangani et al.
MOLECULAR CELL (2013)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
Sharanjot Saini et al.
CLINICAL CANCER RESEARCH (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer
Jeffrey M. Friedman et al.
CELL CYCLE (2009)
The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription
Hee-Bum Kang et al.
FEBS LETTERS (2009)
A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome
Keisuke Nimura et al.
NATURE (2009)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer
Outi R. Saramaki et al.
GENES CHROMOSOMES & CANCER (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
分享论文
